Monster Beverage walks into its Q1 results tomorrow with short sellers in full retreat, a well-timed analyst upgrade landing today, and a stock that — despite a soft week — has quietly recovered 5% from its April lows.
The most striking shift in positioning is the consistent unwinding of short interest. At 2.0% of free float, SI has dropped 15% over the past month — shedding roughly 3.8 million shares. The trend accelerated this week, with SI falling another 5% in five sessions to 19.8 million shares. That is the lowest level in the 30-day window captured here. The ORTEX short score has been drifting lower too, easing from 35.8 in late April to 34.6 now, placing it in the 46th percentile across the universe — firmly in the middle of the pack. There is no squeeze tension here, and there is no crowded-bear thesis either. Short sellers are stepping away, not pressing their bets ahead of the print.
The borrow market is orderly, with a minor wrinkle. Cost to borrow has climbed to 0.44%, a 28% jump on the week — notable in percentage terms, but in absolute terms still negligible for a stock of this size. Availability of shares to borrow remains ample; with utilisation around 1.2%, well below the 52-week peak of 2.7%, there is no sign the lending pool is under any strain. Options positioning is equally relaxed. The put/call ratio at 1.14 is essentially flat to its 20-day average of 1.13. The z-score of 0.28 implies no unusual hedging demand. The market is neither bracing for a disaster nor pricing in a windfall — just waiting.
The analyst picture is more interesting. Today's upgrade from Rothschild & Co — moving MNST to Buy with a $90 target, up from $76 — is the first upward rating move in months and lands less than 24 hours before the print. It contrasts sharply with the prevailing direction of recent analyst activity: JP Morgan trimmed its target to $78 last Monday while holding Neutral, Stifel cut to $90 (from $92) in late April, and Wells Fargo and UBS both reduced targets in early April, all while maintaining positive or neutral ratings. The broad direction of travel has been cautious, with targets migrating down toward the $78–$90 range. The consensus remains Buy, with 12 buys against 10 holds, and the mean target of $85.63 implies roughly 13% upside from the current $75.80. At a P/E of 32.4x and EV/EBITDA of 23.7x, the stock carries a meaningful premium — which explains why the Street keeps the leash tight even as the bulls stay constructive. RBC noted this week that Q1 revenue looks solid but cost pressures could weigh on margins, a tension that bulls and bears agree is the critical variable for this print.
The bull case centres on Monster's dominant brand position in the energy drink category, its distribution leverage through Coca-Cola, and a pipeline of new product launches. The bear case is more structural: heavy reliance on one category that faces regulatory scrutiny and media pressure, an international growth story that still trails Red Bull, and a foray into alcohol that some see as a distraction. Neither side is finding much to trade on in the short data right now — which puts the earnings release squarely in the frame as the event that resolves the standoff.
History from the most recent prior print offers a reference point. The February 26 Q4 2025 report saw essentially no reaction on day one — the stock moved less than 0.1%. The five-day window was harsher, with shares falling 10% in the week that followed. That 5-day drift, rather than the initial print, is the pattern worth watching: whether tomorrow's numbers land cleanly or leave a margin question unanswered, the week after the report has historically done more damage than the day itself. With KO raising full-year guidance after a strong Q1 beat just days ago — a modest positive read-through for distribution volumes — the setup for Monster is at least not hostile. Peer CELH is up 2.8% on the week, another mild positive read for energy drink category sentiment. The number to watch tomorrow is not the revenue line, but gross margin: that is where the cost-pressure narrative either sticks or falls apart.
See the live data behind this article on ORTEX.
Open MNST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
